<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">Problems of Social Hygiene, Public Health and History of Medicine</journal-id><journal-title-group><journal-title>Problems of Social Hygiene, Public Health and History of Medicine</journal-title></journal-title-group><issn publication-format="print">0869-866X</issn><issn publication-format="electronic">2412-2106</issn><publisher><publisher-name>Joint-Stock Company Chicot</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">2097</article-id><article-id pub-id-type="doi">10.32687/0869-866X-2023-31-s2-1153-1158</article-id><article-categories><subj-group subj-group-type="heading"><subject>Научная статья</subject></subj-group></article-categories><title-group><article-title>RISK FACTORS, TREATMENT ORGANIZATION AND QUALITY INDICATORS FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN PRIMARY CARE SETTINGS: DUTCH EXPERIENCE</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Andreev</surname><given-names>D. A.</given-names></name><email></email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kamynina</surname><given-names>N. N.</given-names></name><email></email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff id="aff-1">Research Institute for Healthcare Organization and Medical Management, 115088, Moscow, Russia</aff><pub-date date-type="epub" iso-8601-date="2023-12-02" publication-format="electronic"><day>02</day><month>12</month><year>2023</year></pub-date><volume>31</volume><issue>\S2</issue><fpage>1153</fpage><lpage>1158</lpage><history><pub-date date-type="received" iso-8601-date="2025-08-05"><day>05</day><month>08</month><year>2025</year></pub-date></history><permissions><copyright-statement>Copyright © 1970,</copyright-statement><copyright-year>1970</copyright-year></permissions><abstract>Introduction. Chronic obstructive pulmonary disease (COPD), usually in advanced stages, is associated with high mortality, being the third leading cause of death worldwide. In the Netherlands, care delivery to patients with COPD has become a focus of the regional medical community, since the COPD death rates in this country are higher than the European Union average. However, between 2011 and 2021, the number of people with COPD (under follow-u by general practitioners) decreased. The experience of this country is interesting, as a large set of measures to improve the situation has been developed and implemented in this region. The purpose of the study was to analyze the experience of the Netherlands in organizing medical care for COPD in primary care settings. Material and methods. The search for scientific literature sources was carried out using the PubMed database and Google system. The search time horizon equaled to 5 years. Results. In the Netherlands, in the system of care delivery to patients with COPD, primary care settings are heavily burdened. The article summarizes approaches to identify COPD risk factors, summarizes current clinical recommendations as of December 2022, and highlights findings of the study on medical digital platforms with the potential to organize continuous monitoring of patients. The paper exemplifies criteria for assessing the treatment quality in specialized care settings, including primary care. Discussion. It is assumed that the most effective measure to further improve efficacy of COPD treatment is the introduction of remote digital medical devices. A possible integration of the updated standards and quality indicators into digital services will further strengthen the concept of continuous automated remote monitoring of COPD patients. Evidence-based selection and introduction of effective digital solutions into current practice will improve quality of care delivery to patients.</abstract><kwd-group xml:lang="en"><kwd>chronic obstructive pulmonary disease</kwd><kwd>risk factor’</kwd><kwd>standards and quality of medical care</kwd><kwd>information technologies</kwd><kwd>healthcare organization</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>хроническая обструктивная болезнь лёгких</kwd><kwd>факторы риска</kwd><kwd>стандарты и качество медицинской помощи</kwd><kwd>цифровизация</kwd><kwd>организация здравоохранения</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Hajat C, Stein E. The global burden of multiple chronic conditions: A narrative review // Prev. Med. rep. 2018. Vol. 12. P. 284—293. DOI: 10.1016/j.pmedr.2018.10.008</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Holtjer J. C.S., Bloemsma L. D., Beijers R. J.H.C.G. et al. Identifying risk factors for COPD and adult-onset asthma: an umbrella review // Eur. Respir. Rev. 2023. Vol. 32, N 168. P. 230009. DOI: 10.1183/16000617.0009—2023</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>André S., Conde B., Fragoso E. et al. COPD and cardiovascular disease // Pulmonology. 2019. Vol. 25, N 3. P. 168—176. DOI: 10.1016/j.pulmoe.2018.09.006</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Fan H., Wu F., Liu J. et al. Pulmonary tuberculosis as a risk factor for chronic obstructive pulmonary disease: a systematic review and meta-analysis // Ann. Transl. Med. 2021. Vol. 9, N 5. P. 390. DOI: 10.21037/atm-20-4576</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Qi C., Sun S. W., Xiong X. Z. From COPD to lung cancer: mechanisms linking, diagnosis, treatment, and prognosis // Int. J. Chron. Obstruct. Pulmon. Dis. 2022. Vol. 17. P. 2603—2621. DOI: 10.2147/COPD.S380732</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Faes K., De Frène V., Cohen J., Annemans L. Resource use and health care costs of COPD patients at the end of life: a systematic review // J. Pain Symptom Manag. 2016. Vol. 52, N 4. P. 588—599. DOI: 10.1016/j.jpainsymman.2016.04.007</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Dewaele S., Van den Bulck S., Gerne L., Vaes B. Development of primary care quality indicators for chronic obstructive pulmonary disease using a Delphi-derived method // NPJ Prim. Care Respir. Med. 2022. Vol. 32, N 1. P. 12. DOI: 10.1038/s41533-022-00276-w</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Biewenga J., Kievits R., Romeijnders A. et al. Hoe verloopt de ‘ketenzorg’ voor COPD in Nederland? Evaluatie van de kwaliteitsindicatoren na drie jaar registratie // Huisarts Nu. 2018. Vol. 47. P. 31—35.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Choi G. J., Kang H. The umbrella review: a useful strategy in the rain of evidence // Korean J. Pain. 2022. Vol. 35, N 2. P. 127—128. DOI: 10.3344/kjp.2022.35.2.127</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>GBD 2015 Chronic Respiratory Disease Collaborators. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990—2015: a systematic analysis for the Global Burden of Disease Study 2015 // Lancet Respir. Med. 2017. Vol. 5, N 9. P. 691—706. DOI: 10.1016/S2213-2600(17)30293-X</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>May S. M., Li J. T. C. Burden of chronic obstructive pulmonary disease: healthcare costs and beyond // Allergy Asthma Proc. 2015. Vol. 36, N 1. P. 4—10. DOI: 10.2500/aap.2015.36.3812</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Hallensleben C., van Luenen S., Rolink E. et al. eHealth for people with COPD in the Netherlands: a scoping review // Int. J. Chron. Obstruct. Pulmon. Dis. 2019. Vol. 14. P. 1681—1690. DOI: 10.2147/COPD.S207187</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Андреев Д. А., Завьялов А. А. Особенности проведения контроля качества и безопасности медицинской деятельности в онкологии (обзор литературы) // Здравоохранение Российской Федерации. 2021. Т. 65, №5. С. 492—497. DOI: 10.47470/0044-197X-2021-65-5-492-497</mixed-citation></ref></ref-list></back></article>
